NewTimeSpace News: CONANT OPTICAL(02276.HK) will spend HKD 21.03 million to repurchase 450 thousand shares on May 8, 2026.
NewTimeSpace News: SBP GROUP(01177.HK) will spend HKD 10.05 million to repurchase 1.86 million shares on May 8, 2026.
NewTimeSpace News, May 8，Frencken Group disclosed in an announcement that it has appointed Mr. Tay Eng Pin as an Independent Non-Executive Director.
NewTimeSpace News, May 8,RKPFOV announced that it has elected to further defer the distribution and arrears of distribution scheduled to be paid on May 18, 2026, to the next distribution payment date.
NewTimeSpace News: SERES(09927.HK) will spend CNY 99.26 million to repurchase 1.1 million shares on May 8, 2026.
NewTimeSpace News, May 8,SDAI Limited disclosed that its wholly-owned subsidiary, SDAI Healthcare Pte. Ltd., has entered into a cooperation agreement with LiveBeyond Pte. Ltd. LiveBeyond will provide strategic and scientific consultancy services to support the Group's commercialisation of longevity-related products, as well as scientific advisory and market credibility endorsement.
NewTimeSpace News, May 8,Keppel DC REIT confirmed in an announcement that a fire occurred on the morning of May 7, 2026 (CET) in the technical room of its Almere Data Centre in the Netherlands. The technical room is separate from the data halls.
NewTimeSpace News, May 9,EC World REIT disclosed in an announcement that its subsidiary, Hangzhou Beigang Logistics Co., Ltd. ("Beigang"), and other entities have been sued by Hangzhou Fenhua Investment LLP (an affiliate of China Zheshang Bank). The Hangzhou Intermediate Court ruled on May 6, 2026, that Beigang and the other defendants are jointly liable for a total amount of approximately RMB 3.515 billion.
NewTimeSpace News: Jiangsu Hengrui Pharmaceutical Co., Ltd. (01276.HK) announced that it has received the Notice of Approval for Clinical Trials for HRS-3005 Tablets issued by the NMPA, approving clinical trials of the product for B-cell malignancies. HRS-3005 Tablets are an innovative anti-tumor drug independently developed by the Company. No similar drugs have been approved for marketing globally to date, with accumulated R&D investment of approximately RMB 26.2 million.
NewTimeSpace News: By the close of trading on May 8, 2026, AIM VACCINE(06660.HK) saw a gain of 21.83% in its share price, closing at HKD 3.07. During the session, it reached an intraday high of HKD 3.14 and touched an intraday low of HKD 2.53.
NewTimeSpace News: AIA(01299.HK) will spend HKD 112.23 million to repurchase 1.29 million shares on May 8, 2026.
NewTimeSpace News: By the close of trading on May 8, 2026, NEW VISION CO(02632.HK) saw a gain of 10.27% in its share price, closing at HKD 116. During the session, it reached an intraday high of HKD 118 and touched an intraday low of HKD 105.
NewTimeSpace News: By the close of trading on May 8, 2026, 160 HEALTH(02656.HK) saw a gain of 44.26% in its share price, closing at HKD 23.14. During the session, it reached an intraday high of HKD 24.54 and touched an intraday low of HKD 15.89.
NewTimeSpace News: By the close of trading on May 8, 2026, FORTIOR(01304.HK) saw a gain of 8.91% in its share price, closing at HKD 150.4. During the session, it reached an intraday high of HKD 154.3 and touched an intraday low of HKD 135.8.
NewTimeSpace News:By the close of trading on May 8, 2026, HAIZHI TECH GP(02706.HK) saw a gain of 25.96% in its share price, closing at HKD 62.1. During the session, it reached an intraday high of HKD 64.4 and touched an intraday low of HKD 49.3.
NewTimeSpace News, CHINAHONGQIAO(01378.HK) will spend HKD 607.79 million to repurchase 18.29 million shares on May 7, 2026.
